Baseline demographics, comorbidities and treatment times
| EV-Only (n=52) | IV+EV (n=38) | ||
|---|---|---|---|
| Age, mean (SD) | 69 (18) | 63 (19) | 0.15 |
| Female patients, n (%) | 32 (61) | 18 (47) | 0.18 |
| ICA-T, n (%)/MCA, n (%) | 8 (15)/44 (85) | 4 (10.5)/34 (89.5) | 0.5 |
| Diabetes, n (%) | 15 (29) | 7 (18) | 0.25 |
| Hypertension, n (%) | 38 (73) | 21 (55) | 0.08 |
| Hyperlipidemia, n (%) | 27 (52) | 17 (45) | 0.5 |
| Atrial fibrillation, n (%) | 24 (46) | 10 (26) | 0.052 |
| Smoking, n (%) | 12 (23) | 5 (13.) | 0.23 |
| NIHSS, median (IQR) | 16 (10–22) | 18 (13–23) | 0.08 |
| CT ASPECTS | 7.5 (6–9) | 8 (7–9) | 0.09 |
| Mean (SD) time from symptom onset, hour:min | 5:19 (4:30) | 1:46 (0:52) | <0.0001* |
| Mean (SD) CT–INR, hour:min | 0:47 (0:32) | 1:00 (0:33) | 0.054 |
| Mean (SD) procedure duration, hour:min | 1:11 (0:33) | 1:16 (0:37) | 0.47 |
*Significance level is set at 0.05.
EV-Only, endovascular therapy alone group; ICA-T, internal carotid artery terminus; IV+EV, endovascular therapy following IV rt-PA administration group; MCA, middle cerebral artery; NIHSS, NIH Stroke Scale.